Pharmacology · Antimicrobials
Every clinical practice hides 8 to 12 antibiotic questions in plain sight. Five mechanisms, one spectrum grid, a handful of resistance tricks, and the toxicity traps written to fool you. Start by beating one.
Every antibiotic does one of five things. Know the mechanism, and coverage and side effects follow logically.
Beta-lactams bind PBPs. Vancomycin binds D-ala-D-ala directly (different target, same wall).
Aminoglycosides and Tetracyclines = "AT 30." Aminoglycosides cause misreading (bactericidal). Tetracyclines block tRNA attachment (bacteriostatic).
"Buy AT 30, CELL at 50", Chloramphenicol, Erythromycin (macrolides), Linezolid, cLindamycin. 🔑 Buy AT 30, CELL at 50, Aminoglycosides & Tetracyclines at 30S. Chloramphenicol, Erythromycin, Linezolid, cLindamycin at 50S.
FQs block gyrase (gram-neg) and topo IV (gram-pos). Metronidazole forms toxic free radicals that shred DNA. Rifampin blocks RNA polymerase.
Double blockade: sulfamethoxazoleSulfa drugs are structural analogs of PABA, they competitively inhibit dihydropteroate synthase, the first step in bacterial folate synthesis. Humans don't have this enzyme (we get folate from food), so sulfa drugs are selectively toxic to bacteria. blocks step 1, trimethoprimTrimethoprim inhibits dihydrofolate reductase (DHFR), the second step in folate synthesis. Bacterial DHFR and human DHFR are structurally different, giving selectivity. But high doses or long courses can still cause folate deficiency in humans → megaloblastic anemia. blocks step 2. Synergistic, two hits on the same pathway.
Tap a drug class. The diagram lights up the exact target. Cell wall, ribosome, DNA, or membrane: every antibiotic in clinical practice lives in one of these spots.
Drag each antibiotic to its mechanism. This is how clinical medicine test it, they give you the drug name and expect you to know the target.